CRISPR Therapeutics (CRSP) Stock Price, Quote, News & History | Benzinga

CRISPR Therapeutics AG (CRSP) Stock Price, Quote, News & History

CRSPNASDAQ

Trade with Public

Trade with Public

$51.60

-0.24-0.46%

At close: Jun 8, 5:00 PM EST

$51.50

-0.10-0.19%

After Hours: 6:46 PM EST

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$52.71

Close

$51.60

Volume / Avg.

1.13M / 1.94M

Day Range

$51.09 - $52.90

52 Wk Range

37.02 - 78.48

Market Cap

$4.97B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

32.41%

Days to Cover

16.54

Recent CRISPR Therapeutics AG News

What's Going On With CRISPR Therapeutics Stock Today?

CRISPR Therapeutics fell Tuesday after unveiling a $350 million convertible notes offering, overshadowing recent momentum from Casgevy uptake and fourth-quarter revenue growth.

Nabaparna Bhattacharya

What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?

FDA biologics chief Vinay Prasad will leave in April, lifting biotech stocks such as uniQure, Capricor, Moderna, and raising hopes for smoother drug approvals.

Vandana Singh

Why Is CRISPR Therapeutics Stock Surging Thursday?

CRSP shares jump on earnings report, strong pipeline for gene therapy. Revenue grows with increased patient treatment and analyst confidence.

Kaustubh Bagalkote

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-399.96M

Investing Cash Flow (TTM)

-422.79M

Financing Cash Flow (TTM)

1.01B

Free Cash Flow (TTM)

-426.18M

Capital Expenditure (TTM)

-26.21M

Net Change in Cash (TTM)

184.59M

Analyst Trends and Forecast

1

Dec 25

0

0

0

0

Jan

3

Feb

1

Mar

1

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.2

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$3.57B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

4792.78

PB Ratio (TTM)

2.81

Earnings Yield % (TTM)

-11.90%

Earnings Yield % (FWD)

-9.84%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$18.42

Company Debt

Total Debt

$585.47M

LT Debt

$585.47M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$423.31M

Debt to Equity

0.43

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$52.71

Close

$51.60

Volume / Avg.

1.13M / 1.94M

Day Range

$51.09 - $52.90

52 Wk Range

37.02 - 78.48

Market Cap

$4.97B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

32.41%

Days to Cover

16.54

About

Sector

Health Care

Industry

Biotechnology

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revol...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy CRISPR Therapeutics (CRSP) stock?

A

You can purchase shares of CRISPR Therapeutics (NASDAQ:CRSP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are CRISPR Therapeutics (CRSP) competitors?

A

There are no as such competitors for CRISPR Therapeutics.

Q

What is the forecast, or price target, for CRISPR Therapeutics (CRSP) stock?

A

CRISPR Therapeutics has a consensus price target of $72.00.

Q

What is the current price for CRISPR Therapeutics (CRSP)?

A

The stock price for CRISPR Therapeutics (NASDAQ: CRSP) is $51.5 last updated June 8, 2026 at 6:46 PM EDT.

Q

Does CRISPR Therapeutics (CRSP) pay a dividend?

A

There are no upcoming dividends for CRISPR Therapeutics.

Q

When is CRISPR Therapeutics (NASDAQ:CRSP) reporting earnings?

A

CRISPR Therapeutics does not have any upcoming earnings scheduled.

Q

Is CRISPR Therapeutics (CRSP) going to split?

A

There is no upcoming split for CRISPR Therapeutics.

Q

What sector and industry does CRISPR Therapeutics (CRSP) operate in?

A

CRISPR Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.